Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy

Absci Corporation ABSI announced that it has entered into a collaboration agreement with pharma goliath, AstraZeneca AZN, to deliver an artificial intelligence (AI)-designed antibody for an undisclosed oncology target. https://www.nasdaq.com/articles/absci-absi-up-on-astrazeneca-deal-to-design-new-cancer-therapy